Savana
Financials
Estimates*
EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | <1m | <1m | 1.4m | 1.6m | 2.5m | 2.5m | 2.5m |
% growth | 330 % | (9 %) | 222 % | 10 % | 56 % | - | - |
EBITDA | <1m | (<1m) | (1.3m) | - | - | - | - |
% EBITDA margin | 38 % | (93 %) | (91 %) | - | - | - | - |
Profit | <1m | (<1m) | (1.3m) | - | - | - | - |
% profit margin | 43 % | (91 %) | (93 %) | - | - | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
€1.3m | Grant | ||
$5.0m | Series A | ||
$15.0m | Series B | ||
* | €22.0m | Late VC | |
Total Funding | CAD62.2m |
Related Content
Recent News about Savana
EditSavana is a healthcare technology company that specializes in transforming unstructured clinical records into structured Big Data using advanced Artificial Intelligence (AI). The company serves a diverse range of clients including private practices, small medical institutions, primary care centers, and larger healthcare organizations. Operating in the health informatics market, Savana's core business model revolves around providing AI-driven solutions that unlock the clinical value embedded within electronic health records (EHRs). By converting free-text clinical notes into actionable data, Savana enables healthcare providers to generate clinical research hypotheses, conduct observational studies, predict clinical events, and understand epidemiological behaviors. The company generates revenue through subscription-based models and customized solutions tailored to the specific needs of its clients. Savana's innovative technology supports decision-making in real-life cases, offering a significant advantage in the rapidly evolving field of health science.
Keywords: AI, Big Data, clinical records, health informatics, EHR, observational studies, epidemiology, healthcare technology, decision support, subscription model.